Continuous systemic 5-fluorouracil infusion in refractory prostatic cancer
โ Scribed by R. Hansen; T. Moynihan; P. Beatty; E. Quebbeman; J. Libnoch; W. Schulte; T. Anderson
- Book ID
- 119046920
- Publisher
- Elsevier Science
- Year
- 1991
- Tongue
- English
- Weight
- 483 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0090-4295
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Ninety-one patients with metastatic colorectal cancer were treated with continuous ambulatory 5-fluorouracil(5FU) infusion 250-300 mg/m2/day through a chronic indwelling central venous catheter. Twenty-six of the 91 patients (29%) had received previous bolus 5FU. Fifty-eight of the 91 patients (64%)
The authors assessed the value of protracted low-dose 5-fluorouracil (5-FU) infusion (250 mg/m\*/day) in refractory breast cancer. Thirty-six patients with prior 5-FU exposure who were not eligible for other investigational therapeutic measures mainly due to extensive prior chemotherapy (median, fou